CIK 0002019410
- Non-accelerated filer
- Emerging growth company
Caris Life Sciences, Inc.
Sign in to watch- Ticker
- CAI
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- TX
- Entity type
- Operating
- EIN
- 852077369
- Phone
- +1 866-771-8946
- Business address
- 750 W JOHN CARPENTER FREEWAY, SUITE 800, IRVING, TX, 75039
- 4 Grant or award See Remarks acquired 63,971 shares (grant or award)
- 4 Grant or award See Remarks acquired 63,971 shares (grant or award)
- 4 Grant or award President acquired 83,162 shares (grant or award)
- 4 Grant or award See Remarks acquired 83,162 shares (grant or award)
- 4 Grant or award See Remarks acquired 320,112 shares (grant or award)
- 4 Grant or award Director acquired 2,492 shares (grant or award)
- 4 Grant or award Director acquired 2,492 shares (grant or award)
- 4 Grant or award Director acquired 2,492 shares (grant or award)
- 4 Grant or award Director acquired 2,492 shares (grant or award)
- 4 Grant or award Director acquired 3,739 shares (grant or award)
- 4 Grant or award Director acquired 5,509 shares (grant or award)
- 4 Option exercise Director acquired 2,500 shares (option exercise)
- 4 Planned sale See Remarks sold 62,250 shares at an average $26.58 ($1,654,461)
- 4 Gift See Remarks gave 1,300 shares (gift)
- 4 Open-market buy See Remarks bought 4,184 shares at $24.09 ($100,793)
- 4 Open-market buy President bought 400 shares at $23.85 ($9,540)
- 4 Option exercise Director acquired 100,000 shares (option exercise)
- 4 Shares withheld for taxes Director gave up 139,517 shares (to pay taxes)
- 4 Shares withheld for taxes President gave up 63,509 shares (to pay taxes)
- 4 Shares withheld for taxes See Remarks gave up 141,956 shares (to pay taxes)
Page 2 of 4 · 67 filings